Abstract
The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Protein & Peptide Letters
Title:Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Volume: 25 Issue: 7
Author(s): Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam and Mohammad Amjad Kamal*
Affiliation:
- Novel Global Community Educational Foundation, Sydney,Australia
Abstract: The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Export Options
About this article
Cite this article as:
Niazi Rasul Zahid , Khan Naqab , Khan Samiullah , Alam Mehboob and Kamal Amjad Mohammad *, Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders, Protein & Peptide Letters 2018; 25 (7) . https://dx.doi.org/10.2174/0929866525666180614120407
DOI https://dx.doi.org/10.2174/0929866525666180614120407 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Extrasynaptic GABA<sub>A</sub> Receptors in the Brainstem and Spinal Cord: Structure and Function
Current Pharmaceutical Design Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study
Current Pharmaceutical Design Inhibition of Opioid Receptor Mediated G-Protein Activity After Chronic Administration of Kynurenic Acid and its Derivative without Direct Binding to Opioid Receptors
CNS & Neurological Disorders - Drug Targets Anticholinergic Effects of Oral Antipsychotic Drugs of Typicals Versus Atypicals Over Medium- and Long-Term: Systematic Review and Meta-Analysis
Current Medicinal Chemistry Adult Hippocampal Neurogenesis as Target for the Treatment of Depression
CNS & Neurological Disorders - Drug Targets A Comprehensive Investigation of Molecular Signatures and Pathways Linking Alzheimer’s Disease and Epilepsy <i>via</i> Bioinformatic Approaches
Current Alzheimer Research The Connections Among Autophagy, Inflammasome and Mitochondria
Current Drug Targets New Prospects for the Drug Treatment of Generalized Anxiety Disorder — A Systematic Review
Current Drug Therapy Implementation of Bagged SVM Ensemble Model for Classification of Epileptic States Using EEG
Current Pharmaceutical Biotechnology Editorial [Hot Topic:Ion Channels as a Target for Drug Design (Executive Editor: Kwok-Keung Tai)]
Current Pharmaceutical Design Preface:
Current Topics in Medicinal Chemistry Epigenetic Modification in Neuropathic Pain
Current Pharmaceutical Design Retigabine: Could it be the Next Broad-Spectrum Antiepileptic Drug?
Current Drug Therapy Aliphatic and Aromatic Oxidations, Epoxidation and S-Oxidation of Prodrugs that Yield Active Drug Metabolites
Current Medicinal Chemistry Establishment of a Secondary Screening Assay for P/Q-Type Calcium Channel Blockers
Combinatorial Chemistry & High Throughput Screening Investigation and Need of Bioequivalence Study: Methodology and Regulatory Requirement
Applied Clinical Research, Clinical Trials and Regulatory Affairs From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
Current Neuropharmacology Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Diabetes, Cognitive Function, and the Blood-Brain Barrier
Current Pharmaceutical Design New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases
Current Medicinal Chemistry